Evidence map›Paper›PMID 19841186›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2009

Regulation of airway MUC5AC expression by IL-1beta and IL-17A; the NF-kappaB paradigm.

Tomoyuki Fujisawa, Sharlene Velichko, Philip Thai, Li-Yin Hung, Fei Huang, Reen Wu

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 144 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
144citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

144 citing papers in PubMed, 1 synthesis or guideline pooled it, 240 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Air pollution-induced airway epithelial barrier dysfunction in COPD: a narrative review of mechanisms and therapeutic implications.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  6. Observational
  7. Article
  8. Frontiers in immunology · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Mucins and Their Roles in Asthma.Immunological reviews · 2025
    Review
  13. Article
  14. Review
  15. Staphylococcus aureus regulates Th17 cells and autophagy via STING in chronic eosinophilic rhinosinusitis with nasal polyps.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
    Article
  16. Pulmonary-delivered Anticalin Jagged-1 antagonists reduce experimental airway mucus hyperproduction and obstruction.American journal of physiology. Lung cellular and molecular physiology · 2025
    Article
  17. Pyronaridine InhibitedBiomolecules & therapeutics · 2024
    Article
  18. Article
  19. Article
  20. Article

84 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Tomoyuki FujisawaCenter of Comparative Respiratory Biology and Medicine, University of California, Davis, CA 95616, USA.
Sharlene Velichko
Philip Thai
Li-Yin Hung
Fei Huang
Reen Wu
University of California, Davis · US

Funding

ROLE OF EPITHELIAL CELLS IN OZONE-NITROGEN DIOXIDE INTERACTIONP01ES000628 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI PLOPPER, CHARLES GEORGE · 1985 to 2010
$12.5M
Roles of IL-17-induced gene expression in airway epithelial host defenseR01HL077902 · NHLBI · UNIVERSITY OF CALIFORNIA DAVIS · PI WU, REEN · 2005 to 2013
$2.8M
Programming Airway Epithelial Differentiation by RadR01HL077315 · NHLBI · UNIVERSITY OF CALIFORNIA DAVIS · PI WU, REEN · 2004 to 2008
$1.4M
NHLBI NIH HHS HL077315NHLBI NIH HHS HL077902NHLBI NIH HHS R01 HL077315NHLBI NIH HHS R01 HL077902NIEHS NIH HHS ES00628NIEHS NIH HHS P01 ES000628
6 · The paper itself

Abstract

Mucin over-production is one of the hallmarks of chronic airway diseases such as chronic obstructive pulmonary disease, asthma, and cystic fibrosis. NF-kappaB activation in airway epithelial cells has been shown to play a positive inflammatory role in chronic airway diseases; however, the role of NF-kappaB in mucin gene expression is unresolved. In this study, we have shown that the proinflammatory cytokines, IL-1beta and IL-17A, both of which utilize the NF-kappaB pathway, are potent inducers of mucin (MUC)5AC mRNA and protein synthesis by both well-differentiated primary normal human bronchial epithelial cells and the human bronchial epithelial cell line, HBE1. MUC5AC induction by these cytokines was both time- and dose-dependent and occurred at the level of promoter activation, as measured by a reporter gene assay. These effects were attenuated by the small molecule inhibitor NF-kappaB inhibitor III, as well as p65 small-interfering RNA, suggesting that the regulation of MUC5AC expression by these cytokines is via an NF-kappaB-based transcriptional mechanism. Further investigation of the promoter region identified a putative NF-kappaB binding site at position-3594/-3582 in the promoter of MUC5AC as critical for the regulation of MUC5AC expression by both IL-1beta and IL-17A. Chromatin immunoprecipitation analysis confirmed enhanced binding of the NF-kappaB subunit p50 to this region following cytokine stimulation. We conclude that an NF-kappaB-based transcriptional mechanism is involved in MUC5AC regulation by IL-1beta and IL-17A in the airway epithelium. This is the first demonstration of the participation of NF-kappaB and its specific binding site in cytokine-mediated airway MUC5AC expression.

Indexed as

BronchiCell LineEnzyme InhibitorsGene Expression RegulationHumansInterleukin-17Interleukin-1betaMucin 5ACNF-kappa BPromoter Regions, GeneticRecombinant ProteinsRespiratory MucosaRNA, MessengerRNA, Small InterferingTranscription Factor RelATransfectionEnzyme InhibitorsInterleukin-17Interleukin-1betaMucin 5ACNF-kappa BRecombinant ProteinsRNA, MessengerRNA, Small InterferingTranscription Factor RelA

Identifiers

PMID19841186
PMCPMC4623590
OpenAlexW2161893481

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.